Low platelet-poor plasma levels of serotonin in adult autistic patients

Neuropsychobiology

Volumn 50, Issue 2, 2004, Pages 157-160

  Spivak, Baruch ^a,b   Golubchik, Pavel ^b   Mozes, Tamar ^a,b   Vered, Yaffa ^a,c   Nechmad, Allon ^d   Weizman, Abraham ^a,d   Strous, Rael D ^a,e  

^a TEL AVIV UNIVERSITY   (Israel)

^b NESS ZIONA MENTAL HEALTH CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d GEHA MENTAL HEALTH CENTER   (Israel)

^e BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

Author keywords

Aggression; Autistic disorder; Platelet poor plasma; Serotonin

Indexed keywords

SEROTONIN;

ADULT; AGE DISTRIBUTION; ARTICLE; AUTISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EVALUATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RATING SCALE; SEROTONIN BLOOD LEVEL; SEX RATIO; SYMPTOMATOLOGY;

ADULT; AUTISTIC DISORDER; BLOOD PLATELETS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; FEMALE; HUMANS; MALE; PLASMA; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN;

EID: 4043157181     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079108     Document Type: Article

References (42)

1. Schain RJ, Freedman DX: Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 1961;58:315-320.
2. McBride PA, Anderson GM, Hertzig ME, Sweeney JA, Kream J, Cohen DJ, Mann JJ: Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Arch Gen Psychiatry 1989;46:213-221.
3. Volkmar FR: Pharmacological interventions in autism: Theoretical and practical issues. J Clin Child Psychol 2001;30:80-87.
4. Chugani DC: Role of altered brain serotonin mechanisms in autism. Mol Psychiatry 2002;7(suppl 2):S16-S17.
5. Cook EH, Leventhal BL: The serotonin system in autism. Curr Opin Pediatr 1996;8:348-354.
6. Stahl SM: The human platelet: A diagnostic and research tool for the study of biogenic amines in psychiatry and neurologic disorders. Arch Gen Psychiatry 1977;34:509-512.
7. Cook EH Jr, Leventhal BL, Freedman DX: Free serotonin in plasma: Autistic children and their first-degree relatives. Biol Psychiatry 1988;24:488-491.
8. Takahashi S, Kanai H, Miyamoto Y: Reassessment of elevated serotonin levels in blood platelets in early infantile autism. J Autism Child Schizophr 1976;6:317-326.
9. Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J, Chugani HT: Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 1999;45:287-295.
10. First MB, Spitzer RL, Gibbon M, Williams JSW: Structured Clinical Interview for Axis I DSM-IV Disorders, Patient Version (SCID-P). Hebrew Version. Tel Aviv, Jakobsohn, 1994.
11. Mesibov GB, Schopler E, Schaffer B, Michal N: Use of the childhood autism rating scale with autistic adolescents and adults. J Am Acad Child Adolesc Psychiatry 1989;28:538-541.
12. Freeman BJ, Ritvo ER, Yokota A, Ritvo A: A scale for rating symptoms of patients with the syndrome of autism in real life settings. J Am Acad Child Psychiatry 1986;25:130-136.
13. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D: The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986;143:35-39.
14. Tagari PC, Boullin DJ, Davies CL: Simplified determination of serotonin in plasma by liquid chromatography. Clin Chem 1984;30:31-35.
15. Cohen DJ, Shaywitz BA, Johnson WT, Bowers M Jr: Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid. Arch Gen Psychiatry 1974;31:845-853.
16. Narayan M, Srinath S, Anderson GM, Meundi DB: Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry 1993;33:630-635.
17. Cook EH Jr, Arora RC, Anderson GM, Berry-Kravis EM, Yan SY, Yeoh HC, Sklena PJ, Charak DA, Leventhal BL: Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci 1993;52:2005-2015.
18. Leboyer M, Philippe A, Bouvard M, Guilloud-Bataille M, Bondoux D, Tabuteau F, Feingold J, Mouren-Simeoni MC, Launay JM: Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry 1999;45:158-163.
19. Anderson GM, Horne WC, Chatterjee D, Cohen DJ: The hyperserotonemia of autism. Ann NY Acad Sci 1990;600:331-340.
20. McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH: A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996;53:1001-1008.
21. McDougle CJ, Kresch LE, Posey DJ: Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors. J Autism Dev Disord 2000;30:427-435.
22. Namerow LB, Thomas P, Bostic JQ, Prince J, Monuteaux MC: Use of citalopram in pervasive developmental disorders. J Dev Behav Pediatr 2003;24:104-108.
23. McDougle CJ, Naylor ST, Cohen DJ, Aghajanian GK, Heninger GR, Price LH: Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 1996;53:993-1000.
24. Rotman A, Caplan R, Szekely GA: Platelet uptake of serotonin in psychotic children. Psychopharmacology (Berl) 1980;67:245-248.
25. 3H- serotonin uptake by platelets in infantile autism and developmental language disorder (including five pairs of twins). J Autism Dev Disord 1986;6:69-76.
26. Reichelt KL, Knivsberg AM: Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Nutr Neurosci 2003;6:19-28.
27. Launay JM, Ferrari P, Haimart M, Bursztejn C, Tabuteau F, Braconnier A, Pasques-Bondoux D, Luong C, Dreux C: Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children. Neuropsychobiology 1988;20:1-11.
28. Anderson GM, Gutknecht L, Cohen DJ, Brailly-Tabard S, Cohen JH, Ferrari P, Roubertoux PL, Tordjman S: Serotonin transporter promoter variants in autism: Functional effects and relationship to platelet hyperserotonemia. Mol Psychiatry 2002;7:831-836.
29. Andres C: Molecular genetics and animal models in autistic disorder. Brain Res Bull 2002;57:109-119.
30. Lamb JA, Parr JR, Bailey AJ, Monaco AP: Autism: In search of susceptibility genes. Neuromolecular Med 2002;2:11-28.
31. Abramson RK, Wright HH, Carpenter R, Brennan W, Lumpuy O, Cole E, Young SR: Elevated blood serotonin in autistic probands and their first-degree relatives. J Autism Dev Disord 1989;19:397-407.
32. Leventhal BL, Cook EH Jr, Morford M, Ravitz A, Freedman DX: Relationships of whole blood serotonin and plasma norepinephrine within families. J Autism Dev Disord 1990;20:499-511.
33. Piven J, Tsai GC, Nehme E, Coyle JT, Chase GA, Folstein SE: Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord 1991;21:51-59.
34. Yirmiya N, Pilowsky T, Nemanov L, Arbelle S, Feinsilver T, Fried I, Ebstein RP: Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am J Med Genet 2001;105:381-386.
35. Tordjman S, Gutknecht L, Carlier M, Spitz E, Antoine C, Slama F, Carsalade V, Cohen DJ, Ferrari P, Roubertoux PL, Anderson GM: Role of the serotonin transporter gene in the behavioral expression of autism. Mol Psychiatry 2001;6:434-439.
36. Yonan AL, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA, Grunn A, Juo SH, Terwilliger JD, Liu J, Cantor RM, Geschwind DH, Gilliam TC: A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet 2003;73:886-897.
37. Fatemi SH, Realmuto GM, Khan L, Thuras P: Fluoxetine in treatment of adolescent patients with autism: A longitudinal open trial. J Autism Dev Disord 1998;28:303-307.
38. McDougle CJ, Stigler KA, Posey DJ: Treatment of aggression in children and adolescents with autism and conduct disorder. J Clin Psychiatry 2003;64(suppl 4):16-25.
39. Chugani DC, Muzik O, Rothermel R, Behen M, Chakraborty P, Mangner T, da Silva EA, Chugani HT: Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997;42:666-669.
40. Betancur C, Corbex M, Spielewoy C, Philippe A, Laplanche JL, Launay JM, Gillberg C, Mouren-Simeoni MC, Hamon M, Giros B, Nosten-Bertrand M, Leboyer M: Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry 2002;7:67-71.
41. Ritvo E, Yuwiler A, Geller E, Plotkin S, Mason A, Saeger K: Maturational changes in blood serotonin levels and platelet counts. Biochem Med 1971;5:90-96.
42. August GJ, Raz N, Papanicolaou AC, Baird TD, Hirsh SL, Hsu LL: Fenfluramine treatment in infantile autism. Neurochemical, electrophysiological, and behavioral effects. J Nerv Ment Dis 1984;172:604-612.